Rep. Gilbert Cisneros (D-CA) Sells Medtronic (MDT) Stock
U.S. House member Gilbert Cisneros sold shares of Medtronic, valued between $1,001 and $15,000, as part of his investment activity.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rep. Gilbert Cisneros (D-CA) sold between $1,001 and $15,000 of Medtronic plc ($MDT) stock on May 15, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed June 9, 2026.
Since the trade, $MDT is up 3.2% after 1 week, up 5.5% after 1 month and up 26.6% to date (from the $74.86 close on May 15, 2026).
Financial Disclosure Report
Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515
Filer Information
- Name:
- Rep. Gilbert Cisneros (D-CA)
- Status:
- Member — House
- State/District:
- CA-31
- Party:
- democrat
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Jun 9, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| Medtronic plc ($MDT) | Sell | May 15, 2026 | $1,001 - $15,000 |
Summary of the filed report, not the original document. Find the original: House financial disclosure search
MDT
Medtronic plc
Key Points
- Gilbert Cisneros sold shares of Medtronic (MDT) valued between $1,001 and $15,000 on May 15, reported on June 9, 2026.
- Medtronic's stock closed at $80.98 on the day of the sale, significantly below its 52-week high of $106.33.
- Analysts hold a consensus rating of 'buy' for Medtronic, with price targets ranging from $95 to $118.
Get $MDT trade alerts by text
We text you when insiders, Congress or big funds trade $MDT. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Medtronic plc alert may contain errors. Disclosures
Overview of the Sale
Gilbert Cisneros, a Democratic member of the U.S. House representing California's 31st district, sold shares of Medtronic plc (NYSE: MDT) valued between $1,001 and $15,000 on May 15, 2026. This transaction was disclosed on June 9, 2026.
Gilbert Cisneros vs. the S&P 500
Hypothetical returns from Gilbert Cisneros's disclosed trades, not real profit or advice. How we model this.
Reasons Behind the Trade
Cisneros's sale comes amid his ongoing investment activity, which has included recent purchases in other companies. It's unclear if this sale reflects a strategic shift in his portfolio or a response to personal financial needs.
Analysts Set New Price Targets
Analysts remain optimistic about Medtronic's future. On October 12, 2026, BTIG maintained a 'Buy' rating with a price target of $99.00. Barclays initiated coverage on October 7 with an 'Equal-Weight' rating and a $95.00 target. TD Cowen reiterated its 'Buy' rating with a target of $110.00 on September 30. Other firms like UBS and Wells Fargo also have 'Buy' ratings with targets of $110.00 and $104.00, respectively. The consensus shows support for Medtronic's stock, indicating confidence in the company's prospects.
Medtronic's Stock Performance
As of the sale date, Medtronic's shares traded at $80.98, which is considerably below its 52-week high of $106.33. This drop suggests potential volatility in the stock, making it an interesting time for investors to watch for further movements. The stock's performance is important as it may reflect broader trends in the medical devices industry, where Medtronic operates.
About Medtronic
Medtronic plc develops and sells device-based medical therapies. The company operates in different segments, including cardiovascular and neuromodulation devices, serving healthcare systems and patients worldwide. Its ongoing innovations and solid market presence make it a key player in the medical devices sector.
What to Watch at Medtronic plc
Investors should keep an eye on Medtronic's next earnings report, set for November 17, 2026, which could provide more insights into its financial health and operational strategies. The recent stock trades by politicians like Cisneros reflect the active interest in Medtronic's performance and may signal investor sentiment in the healthcare sector. Remember that 13F filings and disclosures like this provide only a snapshot of an investor's position at a point in time.
Related Filing Alerts
Source: Gilbert Cisneros's STOCK Act disclosure on $MDT (May 15, 2026). Find the original filing: House financial disclosure search. Written by software, not financial advice. How we make alerts